Works matching IS 03407004 AND DT 2021 AND VI 70 AND IP 11


Results: 28
    1
    3

    Identification of mouse helper epitopes for WT1-specific CD4<sup>+</sup> T cells.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3323, doi. 10.1007/s00262-021-03003-5
    By:
    • Nakajima, Hiroko;
    • Nakata, Jun;
    • Imafuku, Kanako;
    • Hayashibara, Hiromu;
    • Isokawa, Kazuki;
    • Udaka, Keiko;
    • Fujiki, Fumihiro;
    • Morimoto, Soyoko;
    • Hasegawa, Kana;
    • Hosen, Naoki;
    • Hashii, Yoshiko;
    • Nishida, Sumiyuki;
    • Tsuboi, Akihiro;
    • Oka, Yoshihiro;
    • Oji, Yusuke;
    • Sogo, Shinji;
    • Sugiyama, Haruo
    Publication type:
    Article
    4
    5

    A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3337, doi. 10.1007/s00262-021-02986-5
    By:
    • Herting, Cameron J.;
    • Farren, Matthew R.;
    • Tong, Yan;
    • Liu, Ziyue;
    • O'Neil, Bert;
    • Bekaii-Saab, Tanios;
    • Noonan, Anne;
    • McQuinn, Christopher;
    • Mace, Thomas A.;
    • Shaib, Walid;
    • Wu, Christina;
    • El-Rayes, Bassel F.;
    • Shahda, Safi;
    • Lesinski, Gregory B.
    Publication type:
    Article
    6

    Immune checkpoint inhibitors-induced nephropathy: a French national survey.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3357, doi. 10.1007/s00262-021-02983-8
    By:
    • Gérard, Alexandre O.;
    • Andreani, Marine;
    • Fresse, Audrey;
    • Parassol, Nadège;
    • Muzzone, Marine;
    • Pinel, Sylvine;
    • Bourneau-Martin, Delphine;
    • Borchiellini, Delphine;
    • Rocher, Fanny;
    • Esnault, Vincent L. M.;
    • Drici, Milou-Daniel
    Publication type:
    Article
    7

    TARP as antigen in cancer immunotherapy.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3061, doi. 10.1007/s00262-021-02972-x
    By:
    • Vanhooren, Jolien;
    • Derpoorter, Charlotte;
    • Depreter, Barbara;
    • Deneweth, Larissa;
    • Philippé, Jan;
    • De Moerloose, Barbara;
    • Lammens, Tim
    Publication type:
    Article
    8
    9
    10

    Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3249, doi. 10.1007/s00262-021-02934-3
    By:
    • Fear, Vanessa S.;
    • Forbes, Catherine A.;
    • Neeve, Samuel A.;
    • Fisher, Scott A.;
    • Chee, Jonathan;
    • Waithman, Jason;
    • Ma, Shao Kang;
    • Lake, Richard;
    • Nowak, Anna K.;
    • Creaney, Jenette;
    • Brown, Matthew D.;
    • Saunders, Christobel;
    • Robinson, Bruce W. S.
    Publication type:
    Article
    11
    12
    13
    14
    15

    Mannan-BAM, TLR ligands, and anti-CD40 immunotherapy in established murine pancreatic adenocarcinoma: understanding therapeutic potentials and limitations.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3303, doi. 10.1007/s00262-021-02920-9
    By:
    • Uher, Ondrej;
    • Caisova, Veronika;
    • Padoukova, Lucie;
    • Kvardova, Karolina;
    • Masakova, Kamila;
    • Lencova, Radka;
    • Frejlachova, Andrea;
    • Skalickova, Marketa;
    • Venhauerova, Anna;
    • Chlastakova, Adela;
    • Hansen, Per;
    • Chmelar, Jindrich;
    • Kopecky, Jan;
    • Zhuang, Zhengping;
    • Pacak, Karel;
    • Zenka, Jan
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Clinically applicable CD34<sup>+</sup>-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3167, doi. 10.1007/s00262-021-02899-3
    By:
    • van Eck van der Sluijs, Jesper;
    • van Ens, Diede;
    • Thordardottir, Soley;
    • Vodegel, Denise;
    • Hermens, Inge;
    • van der Waart, Anniek B.;
    • Falkenburg, J. H. Frederik;
    • Kester, Michel G. D.;
    • de Rink, Iris;
    • Heemskerk, Mirjam H. M.;
    • Borst, Jannie;
    • Schaap, Nicolaas P. M.;
    • Jansen, Joop H.;
    • Xiao, Yanling;
    • Dolstra, Harry;
    • Hobo, Willemijn
    Publication type:
    Article
    27
    28

    Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3123, doi. 10.1007/s00262-021-02871-1
    By:
    • Verver, Danielle;
    • Grünhagen, Dirk J.;
    • van Akkooi, Alexander C. J.;
    • Aarts, Maureen J. B.;
    • van den Berkmortel, Franchette W. P. J.;
    • van den Eertwegh, Alfonsus J. M.;
    • de Groot, Jan Willem B.;
    • Boers-Sonderen, Marye J.;
    • Haanen, John B. A. G.;
    • Hospers, Geke A. P.;
    • Kapiteijn, Ellen;
    • Piersma, Djura;
    • van Rijn, Rozemarijn S.;
    • Suijkerbuijk, Karijn P. M.;
    • Tije, Albert J.ten;
    • Vreugdenhil, Gerard;
    • Verhoef, Cornelis;
    • van der Veldt, Astrid A. M.
    Publication type:
    Article